Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Phreesia, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
-64.1% vs price
Base Case (Median)
-63.1% vs price
Bull Case (75th pct.)
-22.2% vs price
◇ = Current price | | Bear | Base | Bull
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| PE Comparable | $4.70 | -63.1% | Medium (25%) |
| Graham Number | $4.70 | -63.1% | Low (10%) |
| EV/EBITDA | $4.18 | -67.1% | Medium (20%) |
| EV/FCF | $25.52 | 100.6% | Medium (20%) |
Based on 4 out of 7 methods, PHR appears overvalued at the current price of $12.72. The base case fair value of $4.70 implies 63.1% downside.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.